(19)
(11) EP 1 178 829 A1

(12)

(43) Date of publication:
13.02.2002 Bulletin 2002/07

(21) Application number: 00939304.2

(22) Date of filing: 18.05.2000
(51) International Patent Classification (IPC)7A61K 39/395, A61K 39/42, C12Q 1/00, C12Q 1/70, G01N 33/53
(86) International application number:
PCT/US0013/694
(87) International publication number:
WO 0069/462 (23.11.2000 Gazette 2000/47)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 18.05.1999 US 134702 P

(71) Applicant: SmithKline Beecham Corporation
Philadelphia, PA 19103 (US)

(72) Inventors:
  • GROSS, Mitchell, S.
    Wayne, PA 19087 (US)
  • SWEET, Raymond, W.
    Bala Cynwyd, PA 19004 (US)
  • TAYLOR, Geraldine
    NewburyBerkshire RG20 7NN (GB)

(74) Representative: Giddings, Peter John, Dr. et al
GlaxoSmithKline, Two New Horizons Court
Brentford, Middlesex TW8 9EP
Brentford, Middlesex TW8 9EP (GB)

   


(54) HUMAN MONOCLONAL ANTIBODY